We are currently witnessing the biggest consumer shift in our history, with millions of smokers around the world choosing to switch to less harmful NGP. 

As a result we are increasingly focusing our attention on developing and expanding our NGP portfolio, providing smokers with alternative products in different categories.

NGP offer smokers alternatives to combustible tobacco and are broadly divided into three main categories: vapour, heated tobacco and oral nicotine.

Our work in this area prioritises vapour, the largest and most developed NGP category opportunity.

We want smokers to switch to alternative products with lower health risks. We encourage them to make that change by providing an outstanding vaping experience, underpinned by leading-edge science and high-quality innovation.

To keep up with NGP developments, see the news section on this page or follow us on Twitter @ImperialBrands


Vapour products are battery-powered devices that heat e-liquids to create a vapour which is inhaled by the user. E-liquids are produced in varying nicotine strengths, with nicotine-free variants also available.

These products are fundamentally different from all tobacco-based products and devices; they do not contain tobacco leaf.

A growing number of regulators and public health bodies have concluded that vapour products are less harmful alternatives to smoking and therefore have a role to play in reducing tobacco-related disease. In the UK, for example, Public Health England and the Royal College of Physicians have concluded that vaping is substantially less harmful than smoking.

We are represented in the vaping category by the pioneering brand blu, which is managed by our Fontem Ventures business and celebrates its ten-year anniversary in 2019.

blu has strong established positions in the USA and UK, the world’s two largest vapour markets, and is available in a growing number of other countries including France, Germany, Italy, Russia and Spain.

Vapour products fall into two broad sub-categories: closed or open systems. Closed systems include the fast-growing pod format; simple-to-use devices such as myblu which feature a pre-filled pod of e-liquid to combine power with portability. Open systems enable the user to refill the e-liquid.


Fontem comments on potential FDA guidance

12 September 2019

While respecting the US government’s motivation and responsibility to act on youth vaping, we believe the forthcoming FDA Guidance restricting the sale of flavoured e-vapour products will have unintended consequences.

Fontem responds to reports linking illnesses and deaths in US to vaping products

10 September 2019

It is imperative that the CDC investigates reports linking respiratory illnesses and deaths to the use of vaping products and we urge the publication of the results as soon as possible.

Fontem US statement on court ruling regarding PMTA timeline

12 July 2019

Fontem statement on the ruling by the U.S. District Court for the District of Maryland adjusting the timeline establishing the FDA's PMTA pathway for electronic nicotine delivery systems.

Switching to vaping should be an option for all the world's smokers

29 May 2019

Fontem Ventures, owner of vapour brand blu, calls on the World Health Organisation to recognise the growing evidence that vaping can make a significant contribution to tobacco harm reduction.


NGP technology is evolving fast and we substantially enhanced our scientific and technical capabilities in 2017 with the acquisition of the innovation business Nerudia.

Nerudia is focused on developing a pipeline of vaping and other NGP innovations that will accelerate smoker conversion rates and stop smokers reverting to tobacco.

The investment built on our acquisition of the global patent portfolio for vapour technologies from the original inventor of the e-cigarette Hon Lik in 2013.

Mr Hon was welcomed to our business as the head of our Research and Development team in China – a position he still holds to this day.

We are committed to making a significant contribution to the growing body of research around vaping and other products. This includes assessing their safety and demonstrating the potential to reduce the risk of diseases associated with smoking when adult smokers switch to our NGP. 

We set high standards to meet the ever-evolving needs of consumers and regulators, and to enable the development of new and potentially safer products.


We have added to our growing repertoire of NGP products with our heated tobacco device Pulze, which was launched in a city pilot in Fukuoka, Japan, in May 2019.

For us, this creates greater optionality in parts of the world where vaping is not permitted or where smokers prefer heated tobacco.

As the name implies, these products heat a portion or rod of tobacco, releasing nicotine and other tobacco emissions at substantially lower levels than cigarettes.


Through our Skruf brand, we have a strong position in snus, an oral tobacco product with a long history of use in Scandinavia.

We are making good early progress in expanding our presence in the next generation of oral nicotine products, growing sales of tobacco-free and other variants in Scandinavia and beyond.


Our strategy is aligned to our purpose of creating something better for the world’s smokers and focuses on driving results in three key areas. 


Our sustainability strategy is integral to the long-term success of our business and underpins our drive to create shared value for our stakeholders.


We focus on maximising opportunities for our brands by building the contribution from our Growth and Specialist Brands.